Show simple item record

dc.contributor.authorYasasever, Vildan
dc.contributor.authorSoydinc, Hilal Oguz
dc.contributor.authorDuranyildiz, Derya
dc.contributor.authorTopuz, Erkan
dc.contributor.authorTas, Faruk
dc.contributor.authorGuney, Nese
dc.contributor.authorDerin, Duygu
dc.contributor.authorCamlica, Hakan
dc.date.accessioned2021-03-03T19:51:42Z
dc.date.available2021-03-03T19:51:42Z
dc.date.issued2008
dc.identifier.citationGuney N., Soydinc H. O. , Derin D., Tas F., Camlica H., Duranyildiz D., Yasasever V., Topuz E., "Serum levels of intercellular adhesion molecule ICAM-1 and E-selectin in advanced stage non-small cell lung cancer", MEDICAL ONCOLOGY, cilt.25, sa.2, ss.194-200, 2008
dc.identifier.issn1357-0560
dc.identifier.otherav_56ca4d11-aa48-4b85-9690-3c0ca6990aac
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/61262
dc.identifier.urihttps://doi.org/10.1007/s12032-007-9026-y
dc.description.abstractCell adhesion is a basic count in inter- and intra-cellular communication and plays an important role in tumor progression. This study was conducted to investigate the serum levels of intercellular adhesion molecule (ICAM-1) and E-selectin in patients with advanced stage non-small cell lung cancer (NSCLC) and the relationships with known prognostic parameters and therapy. These serum factors were measured of 57 NSCLC patients pathologically verified before and after chemotherapy in comparison with 24 healthy controls by using ELISA method. Serum levels of ICAM-1 were increased significantly in NSCLC patients compared with the healthy controls (P = 0.006). However, serum E-selectin levels were not significantly different from healthy control groups (0.643). No statistically significant relationships were found between investigated all serum parameters and various characteristics of patients, and the diseases such as stage and tumor burden. Likewise, we also found no correlation between serum ICAM-1 and E-selectin (P = 0.78). We found that serum ICAM-1 levels were decreased owing to the chemotherapy effect, independently from chemotherapy response. However, serum E-selectin levels were not changed by the chemotherapy effect. The median survival of all patients was 11.9 months and 1-year survival rate was 47.6%. We found that patients performance status (P = 0.013), age (P = 0.015), and weight loss (P = 0.007) were prognostic factors for survival. Serum E-selectin levels showed a trend (P = 0.08) related to worse prognosis, however serum ICAM-1 levels were determined as ineffective on survival (P = 0.11). Multivariate analysis revealed that only weight loss (P = 0.005) and E-selectin levels (P = 0.002) remained as an independent prognostic factor for survival in patients with advanced NSCLC. In conclusion, our data suggest that higher serum ICAM-1 can be useful for diagnosis while E-selectin levels have prognostic significance and could be a potential prognostic factor in NSCLC patients.
dc.language.isoeng
dc.subjectOncology
dc.subjectHealth Sciences
dc.subjectDahili Tıp Bilimleri
dc.subjectOnkoloji
dc.subjectİç Hastalıkları
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleSerum levels of intercellular adhesion molecule ICAM-1 and E-selectin in advanced stage non-small cell lung cancer
dc.typeMakale
dc.relation.journalMEDICAL ONCOLOGY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume25
dc.identifier.issue2
dc.identifier.startpage194
dc.identifier.endpage200
dc.contributor.firstauthorID7320


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record